Investing 101

Initial Public Offering 101 If you have been reading any financial media, or even social media, at all throughout 2020, you likely get the feeling that the IPO market has been growing like crazy. This is something my colleague, Ishan Dan, has addressed in his article this week, called IPO market review – who delivered…

Neobank Douugh (ASX: DOU) shares are up 30% at the time of writing, and up a whopping 1100% after a successful backdoor listing on the ASX at 3c. Neobanks (or digital banks) are simply new app-based banks. No branches, no cash, and interaction entirely through a smartphone app. Although dubbed a neobank, Douugh is so…

What ASX stocks to buy if Trump or Biden wins the Presidency? In last week’s article we explored the possibility of a Trump second-term presidency and a Biden Presidency. When it comes to politics, we keep opinions and views separate from investment decisions as they rarely add any great significance to the share market. In…

In a world of stockbrokers, financial planners, advisers, coaches, and wealth managers, who can you trust to invest your money? As a stockbroker that began fifteen years ago, I witnessed first-hand how the financial advice industry underwent significant changes caused by a long list of events such as the Global Financial Crisis, online broking, FOFA…

Shares in leading tech firm, BrainChip Holdings Ltd (ASX:BRN), are up 113% since the start of the month after releasing a positive set of earnings results and a series of product-specific announcements that have been well received, predominantly by retail investors. Firstly, what is BrainChip? If you’ve seen the blockbuster sci-fi Terminator 2 starring Arnold…

Does Buffett still have the magic touch? It seems as if Japan does not get a lot of respect from external investors.

LICs have provided a useful investment tool for self-directed investors for many years, but recent events are once again bringing their structure into question.

A clear correlation has emerged between risk appetite during the COVID-19 pandemic and the age of investors, with Australian ‘millennials’ – aged 24-39 – among the most proactive globally, according to a survey of 1,800 people in six countries. Australian investors of all ages are also among the most bullish globally. The survey was conducted…

In the second of a series on Australian biotech success stories, here are some more representatives of the fascinating medical device cohort on the ASX. Medical Developments International (MVP, $5.97) Market capitalisation: $391 million Three-year total return: 6.3% a year Analysts’ consensus target price: $8.61 (Thomson Reuters) Medical Developments International is the company behind the…

In an environment of low interest rates and seemingly overvalued sharemarkets, advisers are naturally flocking to alternative asset classes to eke out returns. Yet not all alternative assets are created the same. The COVID-19 sell off and subsequent recovery has truly seperated the good from the bad. In this webinar, PIMCOs Chris Santore, will shine…

Gold prices have seen specialist Exchange Traded Fund provider, ETF Securities move beyond $3 billion in assets under management to start the new financial year.

Given the global outlook is clearly one of a high degree of risk, it is surprising that all forms of risk assets seem to continually defy all the negative outlooks. Traditional asset allocations have been heavily tied to equity market growth and the continual decline in risk free interest rates over the past 30 years….